BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7943169)

  • 21. Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.
    Gómez-Tortosa E; Gonzalo I; Fanjul S; Sainz MJ; Cantarero S; Cemillán C; Yébenes JG; del Ser T
    Arch Neurol; 2003 Sep; 60(9):1218-22. PubMed ID: 12975286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic study of age-related change in the posterior pituitary gland focusing on abnormal deposition of tau protein.
    Hashizume M; Takagi J; Kanehira T; Otake K; Mimuro M; Yoshida M; Hashizume Y
    Pathol Int; 2011 Jan; 61(1):13-8. PubMed ID: 21166938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques.
    Sheng JG; Mrak RE; Griffin WS
    J Neurosci Res; 1994 Nov; 39(4):398-404. PubMed ID: 7884819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N epsilon-carboxymethyllysine in brain aging, diabetes mellitus, and Alzheimer's disease.
    Gironès X; Guimerà A; Cruz-Sánchez CZ; Ortega A; Sasaki N; Makita Z; Lafuente JV; Kalaria R; Cruz-Sánchez FF
    Free Radic Biol Med; 2004 May; 36(10):1241-7. PubMed ID: 15110389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebral beta-amyloid deposition is augmented by the -491AA promoter polymorphism in non-demented elderly individuals bearing the apolipoprotein E epsilon4 allele.
    Pahnke J; Walker LC; Schroeder E; Vogelgesang S; Stausske D; Walther R; Warzok RW
    Acta Neuropathol; 2003 Jan; 105(1):25-9. PubMed ID: 12471457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High prevalence of thorn-shaped astrocytes in the aged human medial temporal lobe.
    Schultz C; Ghebremedhin E; Del Tredici K; Rüb U; Braak H
    Neurobiol Aging; 2004 Mar; 25(3):397-405. PubMed ID: 15123344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
    Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
    Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alzheimer's pathology in human temporal cortex surgically excised after severe brain injury.
    Ikonomovic MD; Uryu K; Abrahamson EE; Ciallella JR; Trojanowski JQ; Lee VM; Clark RS; Marion DW; Wisniewski SR; DeKosky ST
    Exp Neurol; 2004 Nov; 190(1):192-203. PubMed ID: 15473992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localization of beta-secretase memapsin 2 in the brain of Alzheimer's patients and normal aged controls.
    Sun A; Koelsch G; Tang J; Bing G
    Exp Neurol; 2002 May; 175(1):10-22. PubMed ID: 12009756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of immunohistochemical and silver staining methods for the detection of diffuse plaques in the aged canine brain.
    Czasch S; Paul S; Baumgärtner W
    Neurobiol Aging; 2006 Feb; 27(2):293-305. PubMed ID: 16002188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Is a false image of the senile plaque in elderly Japanese with leprosy?--pathological findings on the immunohistology].
    Koya G; Tabira T
    Nihon Rai Gakkai Zasshi; 1994 Jul; 63(2):51-4. PubMed ID: 7844063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some morphometric aspects of the brain in senile dementia of the Alzheimer type.
    Terry RD; Peck A; DeTeresa R; Schechter R; Horoupian DS
    Ann Neurol; 1981 Aug; 10(2):184-92. PubMed ID: 7283403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging.
    Markesbery WR; Ehmann WD; Hossain TI; Alauddin M; Goodin DT
    Ann Neurol; 1981 Dec; 10(6):511-6. PubMed ID: 7325600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The "normal" brain. "Abnormal" ubiquitinilated deposits highlight an age-related protein change.
    Pappolla MA; Omar R; Saran B
    Am J Pathol; 1989 Oct; 135(4):585-91. PubMed ID: 2552809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects.
    Vermersch P; David JP; Frigard B; Fallet-Bianco C; Wattez A; Petit H; Delacourte A
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Oct; 19(6):1035-47. PubMed ID: 8584681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aging-associated neuropathology in Werner syndrome.
    Leverenz JB; Yu CE; Schellenberg GD
    Acta Neuropathol; 1998 Oct; 96(4):421-4. PubMed ID: 9797008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic amyloid deposition in old age and dementia of Alzheimer type: the relationship of brain amyloid to other amyloid.
    Yamada M; Tsukagoshi H; Otomo E; Hayakawa M
    Acta Neuropathol; 1988; 77(2):136-41. PubMed ID: 3067504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.